Hemostemix Inc. 2VF0.F Stock
Hemostemix Inc. Price Chart
Hemostemix Inc. 2VF0.F Financial and Trading Overview
| Hemostemix Inc. stock price | 0.03 EUR |
| Previous Close | 0.08 EUR |
| Open | 0.08 EUR |
| Bid | 0.08 EUR x N/A |
| Ask | 0.09 EUR x N/A |
| Day's Range | 0.08 - 0.08 EUR |
| 52 Week Range | 0.08 - 0.31 EUR |
| Volume | 3.1K EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 6.97M EUR |
| Beta (5Y Monthly) | 0.653198 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.02 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
2VF0.F Valuation Measures
| Enterprise Value | 10.48M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -2.871 |
Trading Information
Hemostemix Inc. Stock Price History
| Beta (5Y Monthly) | 0.653198 |
| 52-Week Change | -33.60% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.31 EUR |
| 52 Week Low | 0.08 EUR |
| 50-Day Moving Average | 0.1 EUR |
| 200-Day Moving Average | 0.12 EUR |
2VF0.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 81.09M |
| Float | 69.57M |
| Short Ratio | N/A |
| % Held by Insiders | 11.75% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -246.65% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -3651019 EUR |
| Net Income Avi to Common (ttm) | -4876430 EUR |
| Diluted EPS (ttm) | -0.05 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 272.34K EUR |
| Total Cash Per Share (mrq) | 0.003 EUR |
| Total Debt (mrq) | 4.02M EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.163 |
| Book Value Per Share (mrq) | -0.086 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -6398746 EUR |
| Levered Free Cash Flow (ttm) | -4811998 EUR |
Profile of Hemostemix Inc.
| Country | Germany |
| State | AB |
| City | Calgary |
| Address | 707-7th Avenue SW |
| ZIP | T2P 3H6 |
| Phone | N/A |
| Website | https://hemostemix.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions. The company develops cell therapy products from the patient's own blood, which is a non-invasive source of therapeutic cells. Its lead product is ACP-01, an autologous cell therapy, which is in Phase II clinical trial for the treatment of vascular diseases, such as cardiovascular disease, peripheral arterial disease, angina pectoris, and ischemia in Canada and the United States. The company is also developing various types of cell products, such as synergetic cell populations, neural cell precursors, and cardiomyocyte cell precursors. Hemostemix Inc. is headquartered in Calgary, Canada.
Q&A For Hemostemix Inc. Stock
What is a current 2VF0.F stock price?
Hemostemix Inc. 2VF0.F stock price today per share is 0.03 EUR.
How to purchase Hemostemix Inc. stock?
You can buy 2VF0.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Hemostemix Inc.?
The stock symbol or ticker of Hemostemix Inc. is 2VF0.F.
Which industry does the Hemostemix Inc. company belong to?
The Hemostemix Inc. industry is Biotechnology.
How many shares does Hemostemix Inc. have in circulation?
The max supply of Hemostemix Inc. shares is 94.2M.
What is Hemostemix Inc. Price to Earnings Ratio (PE Ratio)?
Hemostemix Inc. PE Ratio is now.
What was Hemostemix Inc. earnings per share over the trailing 12 months (TTM)?
Hemostemix Inc. EPS is -0.02 EUR over the trailing 12 months.
Which sector does the Hemostemix Inc. company belong to?
The Hemostemix Inc. sector is Healthcare.